miR-34b Targets HSF1 to Suppress Cell Survival in Acute Myeloid Leukemia (Q38764745)

6 September 2017

title

miR-34b Targets HSF1 to Suppress Cell Survival in Acute Myeloid Leukemia (English)

1 reference

6 September 2017

Gangcan Li

1

1 reference

6 September 2017

Yanping Song

2

1 reference

6 September 2017

Yunjie Zhang

3

1 reference

6 September 2017

Hao Wang

4

1 reference

6 September 2017

Jia Xie

5

1 reference

6 September 2017

publication date

1 January 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

24

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

109-116

1 reference

P-cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27.

6 September 2017

cites work

1 reference

12 December 2020

The quest for the 1p36 tumor suppressor

1 reference

12 December 2020

miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia

1 reference

12 December 2020

SnapShot: MicroRNAs in Cancer

1 reference

12 December 2020

Reprogramming of miRNA networks in cancer and leukemia

1 reference

12 December 2020

MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma.

1 reference

12 December 2020

The Beginning of the Road for Non-Coding RNAs in Normal Hematopoiesis and Hematologic Malignancies

1 reference

12 December 2020

HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells

1 reference

12 December 2020

Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance

1 reference

12 December 2020

miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways

1 reference

12 December 2020

Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.

1 reference

12 December 2020

microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia

1 reference

12 December 2020

miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1.

1 reference

12 December 2020

Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia

1 reference

12 December 2020

HSF1 regulation of β-catenin in mammary cancer cells through control of HuR/elavL1 expression

1 reference

12 December 2020

Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells

1 reference

12 December 2020

Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT.

1 reference

12 December 2020

Inhibition of ERK5 enhances cytarabine-induced apoptosis in acute myeloid leukemia cells.

1 reference

12 December 2020

Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia.

1 reference

12 December 2020

The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression

1 reference

12 December 2020

Higher heat shock factor 1 expression in tumor stroma predicts poor prognosis in esophageal squamous cell carcinoma patients

1 reference

12 December 2020

Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia

1 reference

12 December 2020

Rare Cytogenetic Abnormalities and Alteration of microRNAs in Acute Myeloid Leukemia and Response to Therapy

1 reference

12 December 2020

New drugs in acute myeloid leukemia

1 reference

12 December 2020

10.3727/096504016X14611963142254

Identifiers

DOI

1 reference

6 September 2017

1 reference